Psychopharmacology and Psychiatry Updates
Un podcast de Psychopharmacology Institute
Catégories:
213 Épisodes
-
Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19
Publié: 29/09/2021 -
How to Assess Psychotropic Drug Adherence
Publié: 24/09/2021 -
Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)
Publié: 19/09/2021 -
Delirium, Catatonia, and COVID-19
Publié: 14/09/2021 -
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Publié: 09/09/2021 -
Dopamine and Depression: Clinical Considerations
Publié: 04/09/2021 -
Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium
Publié: 30/08/2021 -
New Somatic Treatments for Child and Adolescent Depression
Publié: 25/08/2021 -
Management of Delirium: Nonpharmacologic Strategies
Publié: 20/08/2021 -
Emerging Complementary and Integrative Therapies for Geriatric Mental Health
Publié: 15/08/2021 -
Delirium: Assessment, Consequences, and Sequelae
Publié: 10/08/2021 -
In Search of a Dose-Response Relationship in SSRIs
Publié: 05/08/2021 -
Valproate/Divalproex: Metabolism, Kinetics, and Warnings
Publié: 31/07/2021
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
